Biopolym. Cell. 2025; 41(2):139.
Bioinformatics
In silico prediction of neuroprotective properties of natural compounds using Scutellaria baicalensis as an example
- Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143
Abstract
Aim. To develop, optimize, and evaluate effective in silico models for predicting the neuroprotective and anxiolytic properties of natural compounds using Scutellaria baicalensis as a case study. Methods. Construction and validation of machine learning models. Results. Three machine learning models, constructed using the Random Forest, XGBoost, and LightGBM algorithms, were developed for in silico prediction of the neuroprotective and anxiolytic activity of natural compounds. The classifiers achieved an accuracy of 75–78%. A binary classification approach was proposed, incorporating molecular descriptors and structural fingerprints, which, after preprocessing and optimization, enabled the identification of compounds with potential neuroprotective activity. The study confirms the effectiveness of these modeling approaches in predicting the neuroprotective, anxiolytic properties of S. baicalensis compounds. Application of the models to known phytochemicals from this plant verified previously reported bioactive substances: of 78 analyzed compounds, 46 were predicted to be potentially active. Conclusions. The in silico prediction of neuroprotective properties of bioactive compounds shows promise for screening and identifying phytocomplexes, particularly for applications in modern medicine such as the prevention and management of PTSD and other neurological disorders.
Keywords: in silico, machine learning, molecular descriptors, Scutellaria baicalensis, neuroprotective properties
Full text: (PDF, in English)
References
[1]
Zagrychuk OG, Matiashchuk YO, Korzhovska VV, Milyan II, Polovyi DO, Demyd AE, Zagrychuk HY. Use of in silico research methods for predicting pharmacokinetic properties and searching for biologically active compounds. Pharm Rev. 2024; 3:53-67.
[2]
Volynets GP, Iungin OS, Gudzera OI, Vyshniakova HV, Rybak MY, Moshynets OV, Balanda AO, Borovykov OV, Prykhod'ko AO, Lukashov SS, Maiula TH, Pletnova LV, Yarmoluk SM, Tukalo MA. Identification of novel antistaphylococcal hit compounds. J Antibiot (Tokyo). 2024; 77(10):665-78.
[3]
Li L, Yang L, Yang L, He C, He Y, Chen L, Dong Q, Zhang H, Chen S, Li P. Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine. Chin Med. 2023; 18(1):146.
[4]
Wang ZL, Wang S, Kuang Y, Hu ZM, Qiao X, Ye M. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis. Pharm Biol. 2018; 56(1):465-84.
[5]
Tao F, Cai Y, Deng C, Chen Z, Shen Y, Sun H. A narrative review on traditional Chinese medicine prescriptions and bioactive components in epilepsy treatment. Ann Transl Med. 2023; 11(2):129.
[6]
Zhang K, Pan X, Wang F, Ma J, Su G, Dong Y, Yang J, Wu C. Baicalin promotes hippocampal neurogenesis via SGK1- and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression. Sci Rep. 2016; 6:30951.
[7]
Wang F, Xu Z, Ren L, Tsang SY, Xue H. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin. Neuropharmacology. 2008; 55(7):1231-7.
[8]
de Carvalho RS, Duarte FS, de Lima TC. Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice. Behav Brain Res. 2011; 221(1):75-82.
[9]
Ding S, Zhuge W, Hu J, Yang J, Wang X, Wen F, Wang C, Zhuge Q. Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABAAR-TrkB interaction in minimal hepatic encephalopathy. Psychopharmacology (Berl). 2018; 235(4):1163-78.
[10]
Ma Y, Zhou X, Zhang F, Huang C, Yang H, Chen W, Tao X. The effect of scutellaria baicalensis and its active ingredients on major depressive disorder: a systematic review and meta-analysis of literature in pre-clinical research. Front Pharmacol. 2024; 15:1313871.
[11]
EghbaliFeriz S, Taleghani A, Tayarani-Najaran Z. Central nervous system diseases and Scutellaria: a review of current mechanism studies. Biomed Pharmacother. 2018; 102:185-95.
[12]
Limanaqi F, Biagioni F, Busceti CL, Polzella M, Fabrizi C, Fornai F. Potential Antidepressant Effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea. Antioxidants (Basel). 2020; 9(3):234.
[13]
Taha K. Machine learning in biomedical and health big data: a comprehensive survey with empirical and experimental insights. J Big Data. 2025; 12(1):61.
[14]
Kanber BM, Al Smadi A, Noaman NF, Liu B, Gou S, Alsmadi MK. LightGBM: a leading force in breast cancer diagnosis through machine learning and image processing. IEEE Access. 2024; 12:39811-32.
[15]
Zhang L, Tian Y, Wang J, Deng S, Fan H. Network pharmacology-based research on the effect of Scutellaria baicalensis on osteosarcoma and the underlying mechanism. Medicine (Baltimore). 2023; 102(46):e35957.
[16]
Nguyen-Vo TH, Nguyen L, Do N, Le PH, Nguyen TN, Nguyen BP, Le L. Predicting Drug-Induced Liver Injury Using Convolutional Neural Network and Molecular Fingerprint-Embedded Features. ACS Omega. 2020; 5(39):25432-9.
[17]
Polishchuk MM, Tsyben DV, Kapliuk YI. Information processing using machine learning tools in Python. Computer-Integrated Technologies: Education, Science, Production. 2023; 53:205-9.
[18]
Pinchuk I, Yachnik Y, Goto R, Skokauskas N. Mental health services during the war in Ukraine: 2-years follow up study. Int J Ment Health Syst. 2025; 19(1):11.